Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Leukemia
|
February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting
V H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Blood Cancer Journal
|
October 16, 2012
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects
V André, D Longoni, S Bresolin, et al.
Clinical Immunology (Orlando, Fla.)
|
July 14, 2020
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations
F Saettini, G Fazio, P Corti, et al.
Leukemia
|
March 27, 2009
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
A M Willasch, B Gruhn, T Coliva, et al.
Leukemia
|
April 29, 2015
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
K Malinowska-Ozdowy, C Frech, A Schönegger, et al.
Clinical and Experimental Medicine
|
January 20, 2024
Idiopathic erythrocytosis: a germline disease?
E M Elli, M Mauri, D D'Aliberti, et al.
Leukemia
|
April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia
C Palmi, E Vendramini, D Silvestri, et al.
Leukemia
|
February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T Flohr, A Schrauder, G Cazzaniga, et al.
Leukemia
|
October 17, 2003
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program
J Gabert, E Beillard, V H J van der Velden, et al.
Leukemia
|
February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
V H J van der Velden, G Cazzaniga, A Schrauder, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Leukemia
|
February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting
V H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Blood Cancer Journal
|
October 16, 2012
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects
V André, D Longoni, S Bresolin, et al.
Clinical Immunology (Orlando, Fla.)
|
July 14, 2020
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations
F Saettini, G Fazio, P Corti, et al.
Leukemia
|
March 27, 2009
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
A M Willasch, B Gruhn, T Coliva, et al.
Leukemia
|
April 29, 2015
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
K Malinowska-Ozdowy, C Frech, A Schönegger, et al.
Clinical and Experimental Medicine
|
January 20, 2024
Idiopathic erythrocytosis: a germline disease?
E M Elli, M Mauri, D D'Aliberti, et al.
Leukemia
|
April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia
C Palmi, E Vendramini, D Silvestri, et al.
Leukemia
|
February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T Flohr, A Schrauder, G Cazzaniga, et al.
Leukemia
|
October 17, 2003
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program
J Gabert, E Beillard, V H J van der Velden, et al.
Leukemia
|
February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
V H J van der Velden, G Cazzaniga, A Schrauder, et al.
Page
of 7